Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Curious about what benefits come with credit cards? Discover rewards, cashback offers, and other advantages to help you choose wisely.
16,461 articlesWegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
A cybersecurity ETF surged roughly 40% in the last month, signaling a shift in investor sentiment toward AI-enabled d...
A federally funded health study tied to the Biden administration finds no safe level of alcohol and warns risks rise ...
Artificial intelligence is delivering measurable efficiency in health care, but the race now focuses on who benefits—...
As of mid-2026, the VOO vs VTI decision remains the key allocation choice for U.S. stock portfolios. This report brea...
As UAD 3.6 rolls out, lenders should view reset as a strategic inflection point — a chance to retool data, adjust ris...
SBI Shinsei Bank launches a three-month crypto deposit reward campaign, offering 20% of interest as vouchers redeemab...
Crypto markets rebound as ripple’s (xrp) potential and Solana price outlook draw attention. Key on-chain data and ins...
Anthropic moved to disable access to its Fable 5 and Mythos 5 models after a U.S. export controls directive barred fo...
When a company’s CEO purchases thousands of shares, investors sit up and take notice. This article breaks down Brady ...
An obscure AI-focused ETF has outperformed the Nasdaq by concentrating on hard-to-access AI players in Korea and Taiw...
As the AI era expands, investors are eyeing a broader landscape beyond Nvidia. This article explores a rising AI infr...